scholarly article | Q13442814 |
P2093 | author name string | John E Moore | |
B Cherie Millar | |||
Bernard D Prendergast | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | emerging pathogen | Q108429945 |
P304 | page(s) | 1-7 | |
P577 | publication date | 2007-10-25 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis | |
P478 | volume | 61 |
Q37114021 | A case of primary infective endocarditis caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy individual and colonization in the family |
Q37305018 | Acute infective endocarditis |
Q37199057 | Antimicrobial resistance in India: A review |
Q33846718 | Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata |
Q61806218 | Case report: Staphylococcus aureus endocarditis in 2 premature newborns |
Q44261574 | Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control study |
Q33875365 | Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia |
Q34189981 | Community-associated methicillin-resistant Staphylococcus aureus endocarditis 'down under': case series and literature review |
Q36818137 | Complementary analysis of the vegetative membrane proteome of the human pathogen Staphylococcus aureus |
Q37291338 | Current challenges in treating MRSA: what are the options? |
Q61639667 | Glycopeptide and daptomycin resistance in community-associated MRSA in the UK |
Q35035275 | Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina |
Q35061048 | Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureus. |
Q37809397 | Infectious endocarditis in pediatric patients: analysis of 19 cases presenting at a medical center |
Q35185044 | Infective endocarditis caused by methicillin-resistant Staphylococcus aureus in a young woman after ear piercing: a case report |
Q91915555 | Invasive community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in children: case series and literature review |
Q33970752 | Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community |
Q56772390 | Methicillin-resistant Staphylococcus aureus--the new zoonosis |
Q37152056 | Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals |
Q37392891 | Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. |
Q37860558 | New trends in infective endocarditis |
Q37247766 | Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA |
Q36771725 | Prospective Analysis Methicillin-resistant Staphylococcus aureus and its Risk Factors |
Q34632750 | Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia |
Q87981071 | Subclavian Artery Pseudoaneurysm in an Unusual Case of Digital Gangrene |
Q37681564 | Treatment strategies for infective endocarditis. |
Search more.